Nova cepa de mpox com potencial pandêmico preocupa cientistas na República do Congo

650 deaths recorded in DRC in previous year; current outbreak primarily affects sex workers in South Kivu region with high transmission rates.
A perfect storm for viral expansion in a region already overwhelmed
Epidemiologist Anne Rimoin describes the convergence of humanitarian crisis, disease, and viral transmission in the DRC.

Em abril de 2024, a República Democrática do Congo declarou uma epidemia de mpox ligada a uma nova variante — a Clade Ib — que combina letalidade elevada, transmissão sexual documentada e a capacidade de escapar dos testes diagnósticos tradicionais. O que emerge do leste do país não é apenas um surto localizado, mas um espelho das vulnerabilidades persistentes que transformam crises regionais em ameaças globais: infraestrutura frágil, populações marginalizadas e um vírus que aprendeu a se mover por novos caminhos. A ciência lança o alerta; resta saber se o mundo ouvirá a tempo.

  • Uma nova variante do mpox, a Clade Ib, foi identificada no leste do Congo com taxa de mortalidade de 10% — o dobro da cepa que causou a emergência global de 2022 — e com capacidade inédita de transmissão sexual documentada.
  • Trabalhadoras do sexo na região de South Kivu são o epicentro do surto, revelando como a vulnerabilidade social amplifica a velocidade e o alcance de um vírus em mutação.
  • A variante apresenta mutações que podem torná-la invisível aos testes diagnósticos convencionais, criando um ponto cego perigoso justamente quando a detecção precoce é mais urgente.
  • Epidemiologistas alertam para uma 'tempestade perfeita': conflito armado, colapso humanitário, cólera e agora uma cepa com potencial pandêmico competindo pelos mesmos recursos de resposta.
  • A corrida contra o tempo exige vigilância reforçada, rastreamento de contatos e campanhas de vacinação direcionadas — medidas que sistemas de saúde sobrecarregados historicamente têm dificuldade de executar com a velocidade necessária.

Em 24 de abril de 2024, a República Democrática do Congo declarou oficialmente uma epidemia de mpox — mas não era o mesmo vírus que o mundo havia enfrentado antes. A doença, que já havia matado 650 pessoas no país no ano anterior, retornava com uma nova face: a variante Clade Ib, identificada por pesquisadores em 15 de abril em um artigo pré-publicado no medRxiv. A linguagem dos cientistas era direta — a cepa possuía "potencial pandêmico".

O surto se concentrava em South Kivu, no leste do país, e o padrão de transmissão revelava algo inédito: a maioria dos infectados eram trabalhadoras do sexo, e o contato sexual emergia como a principal rota de propagação. A Clade Ib não era apenas mais letal que a Clade II — responsável pela emergência global de 2022, com mortalidade de cerca de 4% — mas apresentava mutações capazes de escapar dos testes diagnósticos tradicionais, tornando ainda mais difícil mapear a real dimensão do surto.

A epidemiologista Anne Rimoin, da Universidade da Califórnia, descreveu o cenário como uma tempestade perfeita: pobreza, infraestrutura de saúde precária, conflito armado e a pressão simultânea de outras epidemias, como a cólera. "A combinação cria um risco substancial de que o surto se expanda além da área atual", alertou ela à revista Nature.

A mpox se manifesta como feridas e bolhas dolorosas na pele, com sintomas que surgem até dez dias após a infecção — mas o período de incubação pode chegar a vinte e um dias, mantendo o verdadeiro alcance do surto oculto por semanas. Diante disso, cientistas exigiram ação imediata: vigilância reforçada, rastreamento agressivo de contatos e campanhas de vacinação direcionadas às populações mais expostas. A Organização Pan-Americana da Saúde já distribuía doses a países das Américas, incluindo o Brasil. A corrida havia começado.

On Wednesday, April 24th, the Democratic Republic of Congo officially declared itself in the grip of an mpox epidemic. The announcement sent a tremor through the global scientific community, not simply because of the outbreak itself, but because of what was spreading: a new variant of the virus that researchers believe carries pandemic potential.

The disease, once called monkeypox before the World Health Organization renamed it to avoid stigma and mischaracterization, had already claimed 650 lives in the country over the previous year. But this new wave appeared different. The cases were clustering in South Kivu, a region in the eastern part of the country, and the pattern of transmission suggested something the virus had not done before—or at least not in any documented way. The majority of those infected were sex workers, and the evidence pointed to sexual contact as the primary route of spread.

On April 15th, researchers working in the country published their findings on medRxiv, a platform for studies awaiting peer review. They had identified a new variant, designated Clade Ib, and their language was direct: it possessed "pandemic potential." The variant appeared capable of causing more severe infections with fatality rates reaching 10 percent—double the mortality of the Clade II strain that had triggered the global health emergency in 2022. Beyond raw lethality, the virus had undergone mutations that seemed to allow it to evade traditional diagnostic tests, a development that threatened to complicate outbreak detection and response.

To understand the alarm, context matters. Until now, scientists had catalogued two main types of mpox circulating in Africa. The Clade II variant, found in West Africa, killed roughly 4 percent of those it infected. The Clade I variant, endemic to the Congo Basin in Central Africa, was far deadlier at 10 percent mortality. What made Clade Ib novel was not just its lethality but its apparent ability to transmit through sexual contact—a capacity that seemed to have emerged through genetic changes in the virus itself. The previous global outbreak in 2022, caused by Clade II, may have involved sexual transmission as well, but it had still resulted in approximately one thousand deaths worldwide before emergency vaccination campaigns began.

Anne Rimoin, an epidemiologist at the University of California who has studied mpox since 2002, spoke to Nature about the convergence of dangers. The Democratic Republic of Congo was already reeling from a humanitarian crisis and the aggressive spread of other diseases, including cholera. "The combination leads to a substantial risk of the outbreak escalating beyond the current area," she said. The region's conditions—poverty, limited healthcare infrastructure, ongoing conflict, and now the concentration of infection among a vulnerable population—created what she described as a perfect storm for viral expansion.

The disease itself manifests as painful sores and blisters across the skin, often concentrated on the face, hands, feet, and genitals, though it can affect the entire body. Symptoms typically emerge within ten days of infection, preceded by fever, headache, body aches, swollen lymph nodes, and exhaustion. The incubation period stretches from seven to twenty-one days, meaning the true scope of any outbreak remains hidden for weeks.

Scientists issued an urgent call for action: reinforced surveillance, aggressive contact tracing, support for case management, and targeted vaccination campaigns focused on the most exposed populations. The Pan-American Health Organization had already begun distributing vaccine doses to nations across the Americas, including Brazil, with a two-dose regimen spaced roughly thirty days apart. But the race was on. A virus with pandemic potential, spreading through sexual networks in a region already overwhelmed by crisis, demanded speed and coordination that global health systems have historically struggled to muster.

The combination leads to a substantial risk of the outbreak escalating beyond the current area
— Anne Rimoin, epidemiologist, University of California
Urgent measures needed including surveillance, contact tracing, case management, and targeted vaccination to contain this new Clade Ib outbreak with pandemic potential
— Researchers publishing on medRxiv
The Hearth Conversation Another angle on the story
Inventor

Why does this variant worry scientists more than the 2022 outbreak, which already killed a thousand people?

Model

The 2022 strain was Clade II—less lethal, around 4 percent mortality. This new one is Clade I, the deadlier lineage, but it's acquired the ability to spread sexually. That combination of higher lethality plus easier transmission is what creates pandemic potential.

Inventor

Sex workers in South Kivu—are they being blamed, or is that just epidemiology?

Model

It's epidemiology. They're the population with the highest exposure and transmission rates, which makes them both the most vulnerable and the most visible in outbreak data. But the virus doesn't discriminate. Once it spreads beyond that group, the distinction becomes academic.

Inventor

The source mentions the virus evades diagnostic tests. How does that change the response?

Model

It means you can't catch what you can't see. If traditional tests miss infections, cases go undetected, contacts aren't traced, and the outbreak grows in the blind spots. It's like trying to contain a fire you can't locate.

Inventor

Is there any chance this doesn't become a pandemic?

Model

There's always a chance. Vaccination works. Behavior change works. But the conditions in the DRC—humanitarian crisis, cholera spreading simultaneously, limited healthcare—those are the factors that tip the scales. The virus itself is dangerous. The context makes it catastrophic.

Inventor

What does "pandemic potential" actually mean in scientific terms?

Model

It means the virus has the biological capacity to spread widely across populations and geography, and the epidemiological conditions exist to support that spread. It's not a prediction. It's a warning about what could happen if containment fails.

Contact Us FAQ